🇺🇸 FDA
Patent

US 10513543

Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof

granted A61KA61K2039/55544A61K2039/6037

Quick answer

US patent 10513543 (Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof) held by SHANGHAI UNITED CELL BIOTECHNOLOGY CO., LTD. expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SHANGHAI UNITED CELL BIOTECHNOLOGY CO., LTD.
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/55544, A61K2039/6037, A61K39/0258, A61K39/107